SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-078370
Filing Date
2022-03-17
Accepted
2022-03-17 16:35:40
Documents
5
Effectiveness Date
2022-03-17

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d302181ds8.htm S-8 50467
2 EX-5.1 d302181dex51.htm EX-5.1 7592
3 EX-23.1 d302181dex231.htm EX-23.1 1491
4 EX-FILING FEES d302181dexfilingfees.htm EX-FILING FEES 13569
5 GRAPHIC g302181g0315032914649.jpg GRAPHIC 2529
  Complete submission text file 0001193125-22-078370.txt   77961
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263644 | Film No.: 22749058
SIC: 2834 Pharmaceutical Preparations